ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

NTLA // Intellia Therapeutics Inc.

DIV <GO> NASDAQ RQD COCKPIT → CIK 0001652130 ↗
Health Care • Biotechnology: In Vitro & In Vivo Diagnostic Substances
$12.47 ▼ -0.76 (-5.74%)
MKT CAP: $1.85B • VOL: 4.09M
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
NTLA // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>) SPOT: $12.47
Intellia Therapeutics Inc. (NTLA) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (-35.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).